Makers Laboratories profit and loss

Latest FY26

Revenue: ₹50.3cr+17.2% on FY25
EBITDA: ₹0.7cr−₹2.2 cr in FY25
Net profit: −₹1.7crNo figure a year before
EPS: −₹2.91₹7.87 in FY25

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023

Expenses
	50.3	42.9	49.1	42.5
	0.6	10.9	1.2	1.1
	50.9	53.9	50.2	43.7
	5.5	4.8	7.0	6.4
	22.2	14.6	25.8	16.8
	−1.7	3.9	−3.1	4.0
	9.7	9.0	9.2	7.4
	0.5	0.9	1.6	1.4
	2.8	2.8	2.7	2.4
	13.9	12.8	14.0	11.9
	53.0	48.9	57.2	50.5
	0.7	−2.2	−3.8	−4.1
	−2.1	−5.1	−6.5	−6.5
Profit
	−2.0	4.9	−7.0	−6.8
	−0.3	0.3	−0.0	−0.4
	−0.3	—	−0.0	−0.4
	−1.7	—	−7.0	−6.4
	0.1	−0.0	0.1	−0.0
	−1.6	4.6	−6.8	−6.4
Per share
	−₹2.91	₹7.87	−₹11.78	−₹10.58
	−₹2.91	₹7.87	−₹11.78	−₹10.58
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	24.3	19.6	19.4	15.2
	48.3%	45.6%	39.5%	35.8%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

MAKERSL₹189.18

Makers Laboratories Limited

· Pharma & Health

Annual Quarterly₹ CrorePeersBPLPHARMA JENBURPH KPL NOVARTIND PARNAXLAB SGRL SHUKRAPHAR SUNLOCMcap ₹112 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026
Revenue from Operations	42.5	49.1	42.9	50.3
Other Income	1.1	1.2	10.9	0.6
Total Income	43.7	50.2	53.9	50.9
Expenses
+ Cost of Materials Consumed	6.4	7.0	4.8	5.5
+ Purchases of Stock-in-Trade	16.8	25.8	14.6	22.2
+ Changes in Inventories	4.0	-3.1	3.9	-1.7
+ Employee Benefit Expense	7.4	9.2	9.0	9.7
+ Finance Costs	1.4	1.6	0.9	0.5
+ Depreciation & Amortisation	2.4	2.7	2.8	2.8
+ Other Expenses	11.9	14.0	12.8	13.9
Total Expenses	50.5	57.2	48.9	53.0
EBITDA	-4.1	-3.8	-2.2	0.7
EBIT	-6.5	-6.5	-5.1	-2.1
Profit
Pretax Income	-6.8	-7.0	4.9	-2.0
+ Deferred Tax	-0.4	-0.0	0.3	-0.3
Tax Expense	-0.4	-0.0	—	-0.3
Net Income	-6.4	-7.0	—	-1.7
+ Other Comprehensive Income	-0.0	0.1	-0.0	0.1
Total Comprehensive Income	-6.4	-6.8	4.6	-1.6
Per Share
Basic EPS	-10.58	-11.78	7.87	-2.91
Diluted EPS	-10.58	-11.78	7.87	-2.91
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	15.2	19.4	19.6	24.3
Gross Margin %	35.84	39.54	45.64	48.32

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.